University of British Columbia: Schizophrenia trials

The registry lists 11 Schizophrenia studies with University of British Columbia as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 3 3Phase 4 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Enhancement of Treatment of Delusions in Schizophrenia Through NeuromodulationWithdrawnNCT03062553Not applicable
• The Music Study in Refractory PsychosisStatus unknownNCT02431949
• The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis DisorderStatus unknownNCT02322918
• Study of the Effect of Dosing on Clozapine LevelsWithdrawnNCT02286206Phase 4
• Contrasting Group Therapy Methods for PsychosisTerminatedNCT01764568Not applicable
• Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental IllnessCompletedNCT00714818Phase 3
• Impact of Genetic Counseling for Individuals With Mental IllnessCompletedNCT00713804Phase 3
• Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)WithdrawnNCT00702793Phase 4
• Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art InterventionsCompletedNCT00358709Phase 3
• Risperidone LA Heathcare Resource StudyCompletedNCT00272597Phase 4
• CARE Study: Improving Treatment for the Most Severely Ill With SchizophreniaCompletedNCT00272584Phase 4